ProQR Therapeutics N.V.
PRQR
$1.63
$0.095.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -68.03% | -43.42% | 66.70% | 13.22% | 56.55% |
| Total Depreciation and Amortization | -8.73% | 8.24% | 18.36% | 27.39% | 2.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 94.09% | 251.04% | -50.26% | 30.89% | -1,181.09% |
| Change in Net Operating Assets | -123.42% | 156.19% | -25.97% | -117.86% | 143.49% |
| Cash from Operations | -73.92% | 23.90% | 40.21% | -134.25% | 68.55% |
| Capital Expenditure | 78.12% | 14.80% | 10.19% | -444.99% | -4,972.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 129.51% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.04% | -- | -- | -- | -- |
| Cash from Investing | -155.21% | 5,079.67% | 10.19% | -20,077.78% | 27,646.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 80.40% | -5.09% | 54.56% | -124.32% | -259.61% |
| Issuance of Common Stock | 35,921.61% | -99.34% | 200.00% | -- | -98.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,576.87% | -62.85% | 56.64% | -63.75% | -108.36% |
| Foreign Exchange rate Adjustments | 431.44% | -248.13% | -92.87% | 143.31% | 86.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,751.83% | 231.53% | 36.04% | -176.04% | 69.69% |